pteridines has been researched along with Androgen-Independent Prostatic Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Z | 1 |
| Chen, L | 2 |
| Wang, H | 1 |
| Ahmad, N | 3 |
| Liu, X | 3 |
| Strebhardt, K | 2 |
| Li, J | 1 |
| Karki, A | 1 |
| Hodges, KB | 1 |
| Zoubeidi, A | 1 |
| Ratliff, TL | 1 |
| Konieczny, SF | 1 |
4 other studies available for pteridines and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Inhibition of Plk1 represses androgen signaling pathway in castration-resistant prostate cancer.
Topics: Animals; Cell Cycle Proteins; HEK293 Cells; Humans; Male; Mice; Mice, Nude; Polo-Like Kinase 1; Pros | 2015 |
Drugging Plk1: An attractive approach to inhibit androgen receptor signaling.
Topics: Animals; Cell Cycle Proteins; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Protein Serin | 2015 |
Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant Prostate Cancer.
Topics: Animals; Antimitotic Agents; Axin Protein; beta Catenin; Cdc20 Proteins; Cell Cycle Proteins; Cell L | 2015 |
Combining p53 stabilizers with metformin induces synergistic apoptosis through regulation of energy metabolism in castration-resistant prostate cancer.
Topics: Acetanilides; Antineoplastic Agents; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Drug Synergis | 2016 |